Context-dependent biological variation presents a unique challenge to the reproducibility of
results in experimental animal research, because organisms’ responses to experimental …

To establish diagnostic performance of the cerebrospinal fluid (CSF) biomarkers β-amyloid
peptide (Aβ 1–42 ), total tau-protein (T-tau) and tau phosphorylated at threonine 181 (P-tau …

… Substantial contributions to study conception and design, and analysis and interpretation of
the data were made by Tom Van de Casteele, Piet De Doncker, Erkki Lathouwers, and Frank …

Background Cobicistat is an alternative pharmacoenhancer to ritonavir. In healthy
volunteers, darunavir exposure was comparable when darunavir 800 mg once daily was co-…

Male bottlenose dolphins (Tursiops sp.) in Shark Bay have one of the most complex male
societies outside humans. Two broad mating strategies have been identified in males. In the …

Next to amyloid and tau, synaptic loss is a key pathological hallmark in Alzheimer’s disease,
closely related to cognitive dysfunction and neurodegeneration. Tau is thought to cause …

This study compared the bioavailability of two candidate fixed‐dose combinations (FDCs:
G003 and G004) of darunavir/cobicistat 800/150 mg with that of darunavir 800 mg and ritonavir …

Over the last two decades, awareness of the negative repercussions of flaws in the planning,
conduct and reporting of preclinical research involving experimental animals has been …

Background Pituitary adenylate cyclase-activating polypeptide (PACAP), structurally related
to vasoactive intestinal peptide (VIP), is one of the important mediators in the pathogenesis …

Late-life depression (LLD) is associated with a risk of developing Alzheimer’s disease (AD).
However, the role of AD-pathophysiology in LLD, and its association with clinical symptoms …